2016 Initiating the international collaboration with Pol-Pharma

2016 marked the building of interrelationships with the big Pol-Pharma Polish Pharmaceutical as a Marketing Authorisation Holder, thus rendering Pharmacare the first generic company starting the registration process of Tedalafil 2.5 mg 5 mg 10 mg and 20 mg within the European market.

Share

Copy ©2019 PharmaCare, All Rights Reserved